Search research articles
Contact Us
Filters
Showing results (391-400 of 418) with videos related to
Page
of 42
Sort By:
Cell Reports
|
June 3, 2026
Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations
Konstantinos Tsingas, Monzy Thomas, McKenna Reale, et al.
Science Translational Medicine
|
February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
Jennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
Science (New York, N.Y.)
|
April 29, 2016
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh, Benjamin Izar, Sanjay M Prakadan, et al.
The Journal of Clinical Investigation
|
April 5, 2016
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Gao Zhang, Dennie T Frederick, Lawrence Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
The State of Melanoma: Emergent Challenges and Opportunities
Michael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
The state of melanoma: challenges and opportunities
Glenn Merlino, Meenhard Herlyn, David E Fisher, et al.
Cell Reports. Medicine
|
March 4, 2022
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma
Samuel S Freeman, Moshe Sade-Feldman, Jaegil Kim, et al.
Eclinicalmedicine
|
November 15, 2023
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in <i>BRAF</i> V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
Xue Bai, Ahmed Shaheen, Charlotte Grieco, et al.
Page
of 42
Search research articles
Search
Showing results (391-400 of 418) with videos related to
Sort By:
Page
of 42
Cell Reports
|
June 3, 2026
Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations
Konstantinos Tsingas, Monzy Thomas, McKenna Reale, et al.
Science Translational Medicine
|
February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
Jennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
Science (New York, N.Y.)
|
April 29, 2016
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh, Benjamin Izar, Sanjay M Prakadan, et al.
The Journal of Clinical Investigation
|
April 5, 2016
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Gao Zhang, Dennie T Frederick, Lawrence Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
The State of Melanoma: Emergent Challenges and Opportunities
Michael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
The state of melanoma: challenges and opportunities
Glenn Merlino, Meenhard Herlyn, David E Fisher, et al.
Cell Reports. Medicine
|
March 4, 2022
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma
Samuel S Freeman, Moshe Sade-Feldman, Jaegil Kim, et al.
Eclinicalmedicine
|
November 15, 2023
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in <i>BRAF</i> V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
Xue Bai, Ahmed Shaheen, Charlotte Grieco, et al.
Page
of 42